6533b7d4fe1ef96bd1261f97

RESEARCH PRODUCT

MR Thermometry Data Correlate with Pathological Response for Soft Tissue Sarcoma of the Lower Extremity in a Single Center Analysis of Prospectively Registered Patients.

Franziska EckertUlf LamprechtFrank TraubMichaela UnsoeldBarbara HermesFrank PaulsenDaniel ZipsVlatko PotkrajcicMarcus Scharpf

subject

HyperthermiaCancer Researchmedicine.medical_specialtymedicine.medical_treatmentSingle Centerlcsh:RC254-282Article030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineMedicineMR thermometryradiotherapymedicine.diagnostic_testbusiness.industrySoft tissue sarcomaHyperthermia TreatmentSoft tissueMagnetic resonance imagingSarcomalcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasehyperthermiaRadiation therapyOncology030220 oncology & carcinogenesisSarcomaRadiologybusinesspathological response

description

Background: There is a strong biologic rationale for using locoregional hyperthermia in soft tissue sarcoma and a randomized trial reported significant improvements with hyperthermia. The aim of this study was to describe the opportunities of magnetic resonance (MR)-based thermometry in a cohort of soft tissue sarcoma patients undergoing combined radiotherapy and locoregional hyperthermia. Patients and Methods: For eleven evaluable patients, tumor volume (VTu) and a separate volume for temperature analysis with reliable temperature distribution (Vtherm) were contoured for every hyperthermia treatment (103 therapies). Temperature data were recorded for all tumors and were correlated with clinical features and pathologic response data. Results: Of 48 patients with high-risk soft tissue sarcomas treated with radio(chemo)therapy and locoregional hyperthermia, MR thermometry was possible in 11 (23%) patients. For all patients, the temperature superseded by 90% of VTu (T90(VTu)) and T90 (Vtherm) were in the range of 37&ndash

10.3390/cancers12040959https://pubmed.ncbi.nlm.nih.gov/32295076